SAB Biotherapeutics

SABS

Market cap $182M

Buy

Hold

Sell

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

Avg. target

$9.5

148% upside

High target

positive

0 neutral

negative

Analyst & Firm	Rating	Price Target	Upside Downside	Date
Chardan Capital Keay Nakae 83% 1-yr SABS win rate				17 Nov ‘25 17 days ago
Leerink Partners 100% 1-yr SABS win rate				17 Sep ‘25 2 months ago